Rare esophageal cancer hits younger patients especially hard, Mayo study finds

Image Credit
Mayo Clinic

Esophageal cancer is relatively rare, making up only about 1% of cancer cases diagnosed each year in the U.S. Mayo Clinic researchers have found that esophageal adenocarcinoma, a type of esophageal cancer, has been rising in incidence over the past 40 years, particularly among people under 50. More concerning is that these younger patients tend to be diagnosed when the cancer is already at a more advanced stage, leading to lower survival rates. They report their study findings in a recently published paper in Cancer Epidemiology, Biomarkers & Prevention.

Don Codipilly, M.D., first author on this study, received a certificate in clinical and translational science at the Mayo Clinic Graduate School of Biomedical Sciences. This study was funded in part by an R01 grant from the National Cancer Institute. It was made possible by Mayo Clinic's Center for Clinical and Translational Science (CCaTS).

CTSA Program In Action Goals
Goal 1: Train and Cultivate the Translational Science Workforce